Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study-Reference-Cited by-同舟云学术

Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study

Published:2018-04-19 Issue:5 Volume:218 Page:748-756
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Stevens Marita¹,Rusch Sarah¹,DeVincenzo John²³⁴,Kim Young-In²,Harrison Lisa²,Meals Elizabeth A²,Boyers Alison⁵,Fok-Seang Juin⁵,Huntjens Dymphy¹,Lounis Nacer¹,Mariёn Kris¹,Remmerie Bart¹,Roymans Dirk¹,Koul Anil¹,Verloes René¹

Affiliation:

1. Janssen Research & Development, Beerse, Belgium

2. Children’s Foundation Research Institute, Le Bonheur Children’s Hospital, Memphis

3. Department of Pediatrics, University of Tennessee School of Medicine, Memphis

4. Department of Microbiology, Immunology, and Biochemistry, University of Tennessee School of Medicine, Memphis

5. hVIVO Services Limited, Queen Mary Bioenterprises Innovation Centre, London, United Kingdom

Funder

Janssen Sciences

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/218/5/748/25206901/jiy227.pdf

Reference29 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017

2. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010

3. Respiratory syncytial virus infection in elderly and high-risk adults;Falsey;N Engl J Med,2005

4. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies;Chemaly;Clin Infect Dis,2014

5. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus;Empey;Clin Infect Dis,2010

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory syncytial virus infections in adults: a narrative review;The Lancet Respiratory Medicine;2024-09

2. Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development;Reviews in Medical Virology;2024-08-29

3. Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents;Journal of Medicinal Chemistry;2024-07-06

4. Spiro-Azetidine Oxindoles as Long-Acting Injectables for Pre-Exposure Prophylaxis against Respiratory Syncytial Virus Infections;Journal of Medicinal Chemistry;2024-06-27

5. Role of human challenge trials (HCTs) in drug development for respiratory syncytial virus (RSV);2024-05-24